国际共识解读——抗核抗体HEp-2细胞间接免疫荧光模型及其结果报告方式

抗核抗体HEp-2细胞间接免疫荧光模型及其结果报告方式国际共识解读

胡朝军，周仁芳，张蜀澜，秦晓松，武永康，牛家峰，杨再兴，何敏，王春燕，罗静，黄清水，李晞，张铁汉，李永哲。抗核抗体HEp-2细胞间接免疫荧光模型及其结果报告方式国际共识解读。中华检验杂志, 2016,39（11）:804-810.

---

[1]作者单位：100730中国医学科学院北京协和医学院北京协和医院风湿免疫科风湿免疫病学教育部重点实验室（胡朝军、张蜀澜、李永哲）；温州医科大学附属温岭医院检验科（周仁芳）；中国医科大学附属盛检验科（秦晓松）；四川大学华西医院实验医学科（武永康）；山东省淄博市第一医院检验科（牛家峰）；上海长征医院实验诊断科（杨再兴）；广东省中医院检验科（何敏）；郑州大学第一附属医院肾内科（王春燕）；山西医科大学第二医院风湿免疫科（罗静）；南昌大学第一附属医院检验科（黄清水）；广西医科大学第一附属医院检验科（李晞）；河南新乡医学院附属第三医院检验科（张铁汉）通信作者：李永哲，

电子信箱: [e-mail]

【摘要】

【关键词】抗核抗体；间接免疫荧光法；荧光模型；国际共识；解读

注：橙色部分为必报核型(基础水平报告荧光模型)，绿色部分为选报核型(专家级水平报告荧光模型)（点击放大查看）

图1 抗核抗体HEp-2细胞间接免疫荧光染色模型分类及命名^[6]

注：A图为德国欧蒙试剂HEp-2细胞间接免疫荧光染色RR荧光模型。B图为美国INOVA试剂HEp-2细胞间接免疫荧光染色RR荧光模型。C图为日本MBL试剂HEp-2细胞间接免疫荧光染色RR荧光模型 （点击放大查看）

图2棒环状模型在不同厂家试剂HEp-2细胞间接免疫荧光染色形态（放大20倍）

表1  ANA检测结果报告范例^[9]

参考文献

[1]        E. J.Holborow，D. M. Weir，G. D. Johnson. A serumfactor in lupus erythematosus with affinity for tissue nuclei[J]. Br Med J,1957, 2(5047): 732-4.PMID: 13460368

[2]        M. Mahler，P. L. Meroni，X. Bossuyt，et al. Current concepts andfuture directions for the assessment of autoantibodies to cellular antigensreferred to as anti-nuclear antibodies[J]. J Immunol Res, 2014, 2014: 315179.PMID: 24868563 DOI:10.1155/2014/315179

[3]        N.Agmon-Levin，J. Damoiseaux，C. Kallenberg，etal. International recommendations for the assessment ofautoantibodies to cellular antigens referred to as anti-nuclear antibodies[J].Ann Rheum Dis, 2014, 73(1): 17-23.PMID: 24126457 DOI: 10.1136/annrheumdis-2013-203863

[4]        马东来,张少静,文夫瑞德·斯特克..自身抗体及其免疫荧光模式[M]. 北京：北京科学技术出版社, 2000.

[5]        李永哲，胡朝军，周仁芳，黄清水.自身抗体免疫荧光图谱[M]. 北京：人民卫生出版社, 2014.

[6]        E. K. Chan，J. Damoiseaux，O. G. Carballo，et al. Report of the FirstInternational Consensus on Standardized Nomenclature of Antinuclear AntibodyHEp-2 Cell Patterns 2014-2015[J]. Front Immunol, 2015, 6: 412.PMID: 26347739 DOI:10.3389/fimmu.2015.00412

[7]        P. L.Francescantonio，M. Cruvinel Wde，A. Dellavance，et al. IV Brazilian guidelines for autoantibodies on HEp-2cells[J]. Rev Bras Reumatol, 2014, 54(1): 44-50. PMID: 24878791

[8]        V. M. Gitlits，S. L. Macaulay，B. H. Toh，et al. Novel humanautoantibodies to phosphoepitopes on mitotic chromosomal autoantigens(MCAs)[J]. J Investig Med, 2000, 48(3): 172-82. PMID: 10822897

[9]        J. Damoiseaux，C. A. von Muhlen，I. Garcia-De La Torre，et al. Internationalconsensus on ANA patterns (ICAP): the bumpy road towards a consensus onreporting ANA results[J]. Auto Immun Highlights, 2016, 7(1): 1.PMID: 26831867 DOI:10.1007/s13317-016-0075-0

[10]      E. M. Tan，A. S. Cohen，J. F. Fries，et al. The 1982 revisedcriteria for the classification of systemic lupus erythematosus[J]. ArthritisRheum, 1982, 25(11): 1271-7. PMID: 7138600

[11]      M. Petri，A. M. Orbai，G. S. Alarcon，et al. Derivation andvalidation of the Systemic Lupus International Collaborating Clinicsclassification criteria for systemic lupus erythematosus[J]. Arthritis Rheum,2012, 64(8): 2677-86. PMID: 22553077DOI: 10.1002/art.34473

[12]      C. Vitali，S. Bombardieri，R. Jonsson，et al. Classificationcriteria for Sjogren's syndrome: a revised version of the European criteriaproposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002,61(6): 554-8. PMID: 12006334

[13]      J. M. Amigues，A. Cantagrel，M. Abbal，et al. Comparative study of4 diagnosis criteria sets for mixed connective tissue disease in patients withanti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse[J]. JRheumatol, 1996, 23(12): 2055-62. PMID: 8970041

[14]      F. van denHoogen，D. Khanna，J. Fransen，et al. 2013 classificationcriteria for systemic sclerosis: an American College of Rheumatology/EuropeanLeague against Rheumatism collaborative initiative[J]. Arthritis Rheum, 2013,65(11): 2737-47. PMID: 24122180   DOI:10.1002/art.38098

[15]      M. P. Manns，A. J. Czaja，J. D. Gorham，et al. Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51(6): 2193-213. PMID: 20513004 DOI: 10.1002/hep.23584

[16]      K. Conrad，L. E. Andrade，E. K. Chan，et al. From autoantibody research to standardized diagnosticassays in the management of human diseases - report of the 12th DresdenSymposium on Autoantibodies[J]. Lupus, 2016, 25(8): 787-96. PMID: 27252254 DOI: 10.1177/0961203316644337